{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:48:40Z","timestamp":1782272920185,"version":"3.54.5"},"reference-count":35,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,2]]},"DOI":"10.4269\/ajtmh.19-0086","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T07:00:28Z","timestamp":1582009228000},"page":"1301-1307","source":"Crossref","is-referenced-by-count":13,"title":["Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania"],"prefix":"10.4269","volume":"103","author":[{"given":"Evan M.","family":"Bloch","sequence":"first","affiliation":[{"name":"Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Coles","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Uniformed University of the Health Sciences, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabula","family":"Kasubi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerusha","family":"Weaver","sequence":"additional","affiliation":[{"name":"Dana Center for Preventive Ophthalmology, Johns Hopkins School of Medicine, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakayo","family":"Mrango","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Kilosa, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Munoz","sequence":"additional","affiliation":[{"name":"Dana Center for Preventive Ophthalmology, Johns Hopkins School of Medicine, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Lietman","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California, San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila K.","family":"West","sequence":"additional","affiliation":[{"name":"Dana Center for Preventive Ophthalmology, Johns Hopkins School of Medicine, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/INF.0b013e31824155c9","article-title":"Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children","volume":"31","author":"Coles","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"b2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/37.suppl_C.125","article-title":"A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and\/or soft tissue infections","volume":"37","author":"Montero","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"b3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4269\/ajtmh.2011.11-0046","article-title":"Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children","volume":"85","author":"Coles","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"b4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/378746","article-title":"Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico","volume":"37","author":"Adachi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"b5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jama.292.6.721","article-title":"Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments","volume":"292","author":"Melese","year":"2004","journal-title":"JAMA"},{"key":"b6","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1715474","article-title":"Azithromycin to reduce childhood mortality in sub-Saharan Africa","volume":"378","author":"Keenan","year":"2018","journal-title":"N Engl J Med"},{"key":"b7","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"b8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/430906","article-title":"Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?","volume":"41","author":"Doern","year":"2005","journal-title":"Clin Infect Dis"},{"key":"b9","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.47.9.2765-2769.2003","article-title":"Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae","volume":"47","author":"Batt","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"b10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/655697","article-title":"The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma","volume":"51","author":"Haug","year":"2010","journal-title":"Clin Infect Dis"},{"key":"b11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bjo.87.2.147","article-title":"Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year","volume":"87","author":"Gaynor","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"b12","doi-asserted-by":"crossref","first-page":"e1000377","DOI":"10.1371\/journal.pmed.1000377","article-title":"Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial","volume":"7","author":"Skalet","year":"2010","journal-title":"PLoS Med"},{"key":"b13","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/cid\/cit137","article-title":"Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment","volume":"56","author":"Coles","year":"2013","journal-title":"Clin Infect Dis"},{"key":"b14","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S1473-3099(18)30444-4","article-title":"Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review","volume":"19","author":"O'Brien","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"b15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/clinids\/24.3.356","article-title":"A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae","volume":"24","author":"Leach","year":"1997","journal-title":"Clin Infect Dis"},{"key":"b16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4269\/ajtmh.17-0022","article-title":"Antibiotic resistance in young children in Kilosa district, Tanzania 4 Years after mass distribution of azithromycin for trachoma control","volume":"97","author":"Bloch","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"b17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijantimicag.2015.06.010","article-title":"Antibiotic resistance: an ethical challenge","volume":"46","author":"Littmann","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"b18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0140-6736(15)00547-4","article-title":"Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries","volume":"387","author":"Mendelson","year":"2016","journal-title":"Lancet"},{"key":"b19","first-page":"209","article-title":"The ethical significance of antimicrobial resistance","volume":"8","author":"Littmann","year":"2015","journal-title":"Public Health Ethics"},{"key":"b20","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Eighth Informational Supplement. CLSI Document M100-S28","year":"2018"},{"key":"b21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/ije\/dyu062","article-title":"Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control","volume":"43","author":"Seidman","year":"2014","journal-title":"Int J Epidemiol"},{"key":"b22","doi-asserted-by":"crossref","first-page":"e29407","DOI":"10.1371\/journal.pone.0029407","article-title":"The fitness cost of antibiotic resistance in Streptococcus pneumoniae: insight from the field","volume":"7","author":"Maher","year":"2012","journal-title":"PLoS One"},{"key":"b23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3201\/eid1402.070138","article-title":"Increasing resistance in commensal Escherichia coli, Bolivia and Peru","volume":"14","author":"Bartoloni","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"b24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4269\/ajtmh.2010.09-0143","article-title":"Risk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence study","volume":"82","author":"Kalter","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"b25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrmicro1614","article-title":"The antibiotic resistome: the nexus of chemical and genetic diversity","volume":"5","author":"Wright","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"b26","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3201\/eid1510.090696","article-title":"Escherichia coli as reservoir for macrolide resistance genes","volume":"15","author":"Phuc Nguyen","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"b27","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/cid\/ciy973","article-title":"Mass oral azithromycin for childhood mortality: timing of death after distribution in the MORDOR trial","volume":"68","author":"Porco","year":"2019","journal-title":"Clin Infect Dis"},{"key":"b28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1086\/341414","article-title":"Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal","volume":"35","author":"Fry","year":"2002","journal-title":"Clin Infect Dis"},{"key":"b29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000381271","article-title":"The value of rectal cultures in treatment of sepsis following post-transrectal ultrasound-guided prostate biopsy","volume":"95","author":"Gottesman","year":"2015","journal-title":"Urol Int"},{"key":"b30","doi-asserted-by":"crossref","first-page":"394368","DOI":"10.1155\/2015\/394368","article-title":"Nasopharyngeal bacterial carriage in the conjugate vaccine era with a focus on pneumococci","volume":"2015","author":"Devine","year":"2015","journal-title":"J Immunol Res"},{"key":"b31","doi-asserted-by":"crossref","first-page":"e0166018","DOI":"10.1371\/journal.pone.0166018","article-title":"Pneumococcal carriage in children under five years in Uganda-will present pneumococcal conjugate vaccines be appropriate?","volume":"11","author":"Lindstrand","year":"2016","journal-title":"PLoS One"},{"key":"b32","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1016\/j.vaccine.2017.07.081","article-title":"Carriage prevalence and serotype distribution of Streptococcus pneumoniae prior to 10-valent pneumococcal vaccine introduction: a population-based cross-sectional study in South Western Uganda, 2014","volume":"35","author":"Nackers","year":"2017","journal-title":"Vaccine"},{"key":"b33","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/S2214-109X(14)70224-4","article-title":"Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies","volume":"2","author":"Hammitt","year":"2014","journal-title":"Lancet Glob Health"},{"key":"b34","doi-asserted-by":"crossref","first-page":"297ra114","DOI":"10.1126\/scitranslmed.aab1621","article-title":"Fitness cost of antibiotic susceptibility during bacterial infection","volume":"7","author":"Roux","year":"2015","journal-title":"Sci Transl Med"},{"key":"b35","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/infdis\/jiw402","article-title":"Interplay between antibiotic resistance and virulence during disease promoted by multidrug-resistant bacteria","volume":"215","author":"Geisinger","year":"2017","journal-title":"J Infect Dis"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T17:37:57Z","timestamp":1611769077000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajtmh.org\/doi\/10.4269\/ajtmh.19-0086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9,2]]}},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.19-0086","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]}}}